Brief: Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results
15/11/2021 13:57
Nov 15 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA THERAPEUTICS ANNOUNCES FISCAL 2022 FIRST QUARTER
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* Q1 LOSS PER SHARE $0.25
* ENROLLMENT OF FIRST PATIENT IN 15-PATIENT CONFIRMATORY
STUDY OF
REM-001 IS EXPECTED IN Q2 OF 2022
Source text for Eikon: ID:nPn1t67Vra
Further company coverage: KTRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.